Repare Therapeutics 주식 (NASDAQ: RPTX)

에 대한 최신 뉴스 Repare Therapeutics (NASDAQ:RPTX) 주식

Repare Therapeutics

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Cathie Wood Bets On Baidu As Chinese AI Buzz Intensifies, Ark Loads Up On $12.4 Million Worth Of Stock

Equities

News

Markets

ARKG

ARKK

PATH

PRME

RPTX

2025년 4월 11일 금요일, 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 유아이패스(NYSE:PATH), 프라임 메디슨(NGM:PRME) 및 리페어 테라퓨틱스(NASDAQ:RPTX)의 주식을 매도하는 주목할 만한 거래를 실행했다.

캐시 우드의 아크 인베스트, 유아이패스, 프라임 메디슨 그리고 리페어 테라퓨틱스를 매도

Tech

ETFs

AMZN

ARKF

ARKQ

ARKW

BEAM

COIN

CRSP

MELI

RBLX

2025년 4월 4일 금요일에 캐시 우드가 이끄는 아크 인베스트는 코인베이스 글로벌(NASDAQ:COIN), 아마존닷컴(NASDAQ:AMZN), 크리스퍼 테라퓨틱스 AG(NGM:CRSP), 빔 테라퓨틱스(NASDAQ:BEAM), 유아이패스(NYSE:PATH), 로블록스(NYSE:RBLX), 메르카도리브레(NASDAQ:MELI), 그리고 리페어 테라퓨틱스(NASDAQ:RPTX)를 포함한 여러 저명한 기업에 대해 상당한 거래를 했다.

아크 인베스트, 아마존 주식이 20% 이상 하락한 가운데 매수: 유아이패스, 로블록스 매각

Cathie Wood Defies CoreWeave IPO Slump, Ark Snaps Up $3.6 Million Worth Of Stock In Nvidia-Backed Company

GTLB

HOOD

목요일(3일) 캐시 우드가 이끄는 아크 인베스트는 로빈후드 마켓츠(NASDAQ:HOOD)의 주식을 매입하며 의미 있는 행보를 보였다. 이번 전략적 투자는 로빈후드가 플랫폼을 지속적으로 확장하고 금융 서비스 제공을 강화하면서 이루어졌다.

아크 인베스트, 관세로 인한 매도세 속 로빈후드 주식 139만 달러 상당 매입

Repare Therapeutics Inc

Buybacks

In April 2025, The Board Of Directors Authorized The Repurchase Of Up To $5.0B Common Stock, Replacing The Previous Authorization, Which At That Time Had $1.1B Remaining Due To Repurchases Made Subsequent To Quarter End

Insteel Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIIN#NYSE">IIIN</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.27 by 103.7 percent. The company reported quarterly sales of $160.66 million which beat the analyst consensus estimate of $149.85 million by 7.21 percent. This is a 26.11 percent increase over sales of $127.39 million the same period last year.

Earnings

IIIN

Insteel Indus Q2 2025 Adj EPS $0.55 May Not Be Comparable To $0.27 Estimate, Sales $160.66M Beat $149.85M Estimate

Needham analyst Laura Martin reiterates Perion Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PERI#NASDAQ">PERI</a>) from Hold to Hold.

Reiteration

Analyst Ratings

PERI

Needham Reiterates Hold on Perion Networkto Hold

Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) reported quarterly earnings of $4.51 per share which missed the analyst consensus estimate of $4.84 by 6.82 percent. This is a 8.15 percent decrease over earnings of $4.91 per share from the same period last year. The company reported quarterly sales of $1.14 billion which missed the analyst consensus estimate of $1.20 billion by 4.56 percent. This is a 3.47 percent decrease over sales of $1.18 billion the same period last year.

Earnings Misses

Snap-on Q1 2025 GAAP EPS $4.51 Misses $4.84 Estimate, Sales $1.14B Miss $1.20B Estimate

Earnings Beats

KeyCorp Q1 2025 EPS From Continuing Operations $0.33, Sales $1.773B Beat $1.751B Estimate

D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) reported quarterly earnings of $2.58 per share which missed the analyst consensus estimate of $2.67 by 3.37 percent. This is a 26.7 percent decrease over earnings of $3.52 per share from the same period last year. The company reported quarterly sales of $7.73 billion which missed the analyst consensus estimate of $8.03 billion by 3.71 percent. This is a 15.08 percent decrease over sales of $9.11 billion the same period last year.

D.R. Horton Q2 2025 GAAP EPS $2.58 Misses $2.67 Estimate, Sales $7.73B Miss $8.03B Estimate

Guidance

HOFT

Hooker Furnishings Announces Additional Annualized Cost Savings Of $8M - $10M In FY26

Russian President Vladimir Putin lauded SpaceX and Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk, drawing a comparison between him and Sergei Korolev, the architect of the Soviet Union&#8217;s space victories in the mid-20th century.
What Happened: Putin praised Musk while discussing Russia&#8217;s space policy with students. He drew an analogy between Musk and&nbsp;Sergei Korolev, the chief engineer&nbsp;behind the Soviet Union&#8217;s first manned spaceflight in 1961, reported Reuters.
Putin was <a href="https://tass.com/politics/1944627">quoted </a>by TASS, the state news agency, as saying, &#8220;You know, there&#8217;s&nbsp;a person who lives in&nbsp;the States, you could say&nbsp;that he&#8217;s absolutely crazy about Mars.&#8221; He went on to add, &#8220;Such&nbsp;people rarely appear in the&nbsp;human population, charged with a&nbsp;certain idea. Even though it&nbsp;may seem incredible to me&nbsp;today, after a time such&nbsp;ideas are often realized.&#8221;
This isn&#8217;t the first instance of Putin expressing admiration for Musk, the founder of space technology firm SpaceX. He has previously referred to Musk as &#8220;an outstanding person.&#8221;
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/04/44855242/charlie-munger-once-highlighted-how-warren-buffetts-lifelong-learning-made-berkshire-hathaways-success-possible-and-the-crucial-lesson-you-can-take-from-it" target="_blank" rel="noreferrer noopener">Charlie Munger Once Said Warren Buffett Is A &#8216;Learning Machine&#8217; And That&#8217;s What Lies Beneath Berkshire Hathaway&#8217;s Success From One Decade To Another &#8211; Benzinga</a>
Why It Matters: Notably, <a href="https://benzinga.com/general/space/24/10/41555246/elon-musks-chats-with-vladimir-putin-make-washington-squirm-tesla-ceo-says-top-secret-security-clea">as per a Wall Street Journal report in October</a>, NASA Administrator Bill Nelson expressed concern over reports of suspected conversations between Elon Musk and Russian President Vladimir Putin, stating, &#8220;If the story is true&#8230; then I think that would be concerning, particularly for NASA, for the Department of Defense, for some of the intelligence agencies." SpaceX, which holds numerous high-value government contracts, is the main rocket launch partner for both NASA and the Pentagon.
Meanwhile, Musk, a key advisor to U.S. President Donald Trump, has <a href="https://www.google.com/search?q=musk+ukraine+benzinga&amp;rlz=1C5CHFA_enIN1085IN1086&amp;oq=musk+ukraine+benzinga&amp;gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIGCAEQRRg8MgYIAhBFGDzSAQg1OTY4ajBqNKgCALACAA&amp;sourceid=chrome&amp;ie=UTF-8">become more vocal in his criticism</a> of Ukraine, which has been in conflict with Russia since 2022.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/global/25/04/44856008/china-dismisses-trumps-tariff-numbers-game-files-wto-complaint-talks-can-only-proceed-based-on-mutual" target="_blank" rel="noreferrer noopener">China Dismisses Trump&#8217;s Tariff &#8216;Numbers Game,&#8217; Files WTO Complaint: Talks Can Only Proceed Based On &#8216;Mutual Respect&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

TSLA

Vladimir Putin Hails Elon Musk, Compares Him To Soviet Space Program Pioneer: 'Such People Rarely Appear In The Human Population'

U.S. stock futures rose on Thursday ahead of the long weekend, with Good Friday falling on April 18 and Easter Sunday on April 20. Futures of major benchmark indices were higher in premarket.
<a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">Federal Reserve</a> Chairman Jerome Powell dismissed the possibility of a &#8220;Fed put&#8221; in the near term while speaking in Chicago on Wednesday.
&#8220;We may find ourselves in the challenging scenario in which our dual-mandate goals are in tension. If that were to occur, we would consider how far the economy is from each goal, and the potentially different time horizons over which those respective gaps would be anticipated to close,&#8221; said Powell.
U.S. export restrictions on Nvidia Corp.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) <a href="https://benzinga.com/25/04/44844084/nvidias-h20-chip-ban-could-lead-to-manageable-sales-drop-bank-of-america-says">H20 GPUs</a> pulled the stock market down on Wednesday.
The 10-year Treasury bond yielded 4.32% and the two-year bond was at 3.82%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing an 86.4% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.75%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.83%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>1.02%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.66%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Thursday. The SPY was up 1.03% to $531.05, while the QQQ advanced 1.04% to $448.78, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
U.S. stocks closed sharply lower on Wednesday, driven by a significant sell-off in the semiconductor sector and broader tech weakness.
The iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) experienced a steep decline, with Nvidia Corp. and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) both falling approximately 7% following new export restrictions on Nvidia chips to China.
This news heavily impacted the information technology sector, which, along with consumer discretionary and communication services, recorded the largest losses. In contrast, energy stocks defied the overall downward trend, closing higher.
Among individual companies, Travelers Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) reported better-than-expected first-quarter results, and Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) posted upbeat first-quarter adjusted EPS.
On the economic front, U.S. industrial production fell by 0.3% in March, slightly more than anticipated. However, U.S. retail sales surged 1.4% month-over-month in March, exceeding both the previous month&#8217;s gain and market expectations.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-3.07%</td>
<td>16,307.16</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-2.24%</td>
<td>5,275.70</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.73%</td>
<td>39,669.39</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.03%</td>
<td>1,863.48</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
According to Scott Wren, the senior global market strategist at Wells Fargo, &#8220;current equity levels offer an attractive entry opportunity even with the bounce higher off the recent lows.&#8221;
Wren further emphasized the importance of having a &#8220;plan of action or at least be happy with where you currently stand,&#8221; regardless of individual perspectives on the implemented tariffs.
&#8220;Over the course of the last couple of weeks, we have seen the administration go from an aggressive reciprocal tariff strategy that involved meaningful universal tariffs on virtually all of our trading partners to a pause that suspends most reciprocal tariffs but leaves a 145% levy on imports from China,&#8221; Wren notes.
Despite the tariff uncertainty, Wren&#8217;s firm maintains a view that the U.S. economy was already heading for a slowdown in the first half of the year, even before the current trade strategies were implemented. &#8220;From our perspective, even before the current tariff strategies were deployed, our analysis suggested the economy was going to hit a bump in the road and slow in the first half of this year. That line of thought is still intact,&#8221; Wren states.
Wren also suggests a strategic shift in fixed income, advising investors to &#8220;move money from bonds, specifically the intermediate portion of the yield curve, into mid-cap U.S. equities in an effort to take advantage of the fall in stocks and the rally in bond prices (yields fell).&#8221;
Meanwhile, the <a href="https://www.benzinga.com/government/regulations/25/04/44858165/policy-push-vs-market-pull-dollar-under-pressure-as-reserve-currency-may-be-called-into-question-amid-tariff-turmoil">U.S. dollar is facing pressure</a>, with its &#8220;reserve currency&#8221; status. A recent study titled &#8216;Dollar Upheaval: This Time is Different&#8217; noted a 3.6% depreciation between April 4th and 14th, an unusual move as the dollar typically gains during global volatility.
This suggests a break from traditional market behavior, raising concerns that U.S. Treasuries lose their safe-haven appeal.
"If U.S. Treasuries are no longer viewed as the world's preferred safe asset, then the status of the dollar as the world's reserve currency may be called into question,&#8221; stated the note.
Investors are now <a href="https://www.benzinga.com/news/treasuries/25/04/44857989/gold-nears-3400-mark-experts-point-to-likely-correction-amid-bull-market-rates-will-drop-like-rock">flocking to Gold</a>, which has been hitting fresh highs as it trades above $3,300 per ounce. According to data shared by Charlie Bilello of Creative Planning, the inflation-adjusted gold prices were back at an all-time high, after 45 years, surpassing the prior peak from 1980.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It took 45 years to get there, but inflation-adjusted Gold prices are back at an all-time high, surpassing the prior peak from 1980. <a href="https://twitter.com/search?q=%24GOLD&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$GOLD</a><a href="https://t.co/l5IYmkeySJ">https://t.co/l5IYmkeySJ</a> <a href="https://t.co/bXWisvrl3c">pic.twitter.com/bXWisvrl3c</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1912558536573268362?ref_src=twsrc%5Etfw">April 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Economist Mohamed El-Erian attributed the increasing price of gold to a gradual shift away from the U.S. dollar by some foreign central banks and other entities seeking diversification.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The price of gold registered another record high today, overcoming yet another periodic round of profit-taking by some tactical traders — this as it benefits from the tailwind of slow and steady diversification away from the dollar by some foreign central banks and others.<a href="https://twitter.com/hashtag/gold?src=hash&amp;ref_src=twsrc%5Etfw">#gold</a>… <a href="https://t.co/MKDnxZddv0">pic.twitter.com/MKDnxZddv0</a>
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1912523089557987357?ref_src=twsrc%5Etfw">April 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Thursday and Friday:
<ul>
<li>On Thursday, initial jobless claims data for the week ending April 12 and March&#8217;s housing starts, building permits, and April&#8217;s Philadelphia Fed manufacturing survey data will be released by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>On Friday, San Francisco Fed President Mary Daly will speak at 8:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) fell 0.64% in premarket on Thursday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $7.29 per share on revenue of $111.60 billion.</li>
</ul>
<ul>
<li>DR Horton Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) rose 0.39% as Wall Street expects it to report earnings of $2.65 per share on revenue of $8.03 billion before the opening bell.</li>
</ul>
<ul>
<li>Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) was up 1.38% as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $5.72 per share on revenue of $10.52 billion.</li>
</ul>
<ul>
<li>FNB Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNB#NYSE">FNB</a>) was up 1.14% as it posted better-than-expected earnings for its first quarter on Wednesday.</li>
</ul>
<ul>
<li>Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) jumped 3.45% after reporting a 60% surge in its net profit for the first quarter, topping market expectations.</li>
</ul>
<ul>
<li>Rio Tinto Plc ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) climbed 1.68% after it announced the assessment of the low-carbon aluminum project in India along with AMG Metals &amp; Materials.</li>
</ul>
<ul>
<li>Woodside Energy Group Ltd. ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDS#NYSE">WDS</a>) advanced 2.73% after signing LNG supply agreements with Uniper.</li>
</ul>
<ul>
<li>BP PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) gained 1.08%, and Kosmos Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) was 4.22% higher after BP completed loading the first cargo from the Greater Tortue Ahmeyim LNG project.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 1.02% to hover around $63.11 per barrel.
Gold Spot US Dollar declined 0.57% to hover around $3,324.20 per ounce. Its fresh record high stood at $3,357.81 per ounce. The U.S. Dollar Index spot was higher by 0.10% at the 99.4760 level.
Asian markets advanced on Wednesday, except China&#8217;s CSI 300 index. India's S&amp;P BSE Sensex, Hong Kong's Hang Seng, Japan's Nikkei 225, Australia's ASX 200, and South Korea's Kospi index ended higher. European markets were lower in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44858165/policy-push-vs-market-pull-dollar-under-pressure-as-reserve-currency-may-be-called-into-qu">Policy Push vs. Market Pull: Dollar Under Pressure As &#8216;Reserve Currency May Be Called Into Question&#8217; Amid Tariff Turmoil</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Futures

Commodities

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

NFLX

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

US Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity'

Health Care

General

Aspira Women's Health Expects To Start Trading Under Its New Symbol "AWHL" On Markets Operated By The OTC Markets Group Today 17 April, Replacing AWH Ticker

Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.98 by 6.12 percent. This is a 48.39 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $280.48 million which missed the analyst consensus estimate of $284.80 million by 1.52 percent. This is a 9.42 percent increase over sales of $256.33 million the same period last year.

TCBI

Texas Capital Bancshares Q1 2025 Adj EPS $0.92 Misses $0.98 Estimate, Sales $280.48M Miss $284.80M Estimate

<a href="https://www.reuters.com/business/aerospace-defense/musks-spacex-is-frontrunner-build-trumps-golden-dome-missile-shield-2025-04-17/" title="https://www.reuters.com/business/aerospace-defense/musks-spacex-is-frontrunner-build-trumps-golden-dome-missile-shield-2025-04-17/">https://www.reuters.com/business/aerospace-defense/musks-spacex-is-frontrunner-build-trumps-golden-dome-missile-shield-2025-04-17/</a>

Rumors

Contracts

PLTR

Reuters Reported SpaceX, Palantir Emerge As Frontrunners For Key Role In Trump's Golden Dome Missile Defense Shield

Biotech

Large Cap

Earendil Labs And Sanofi Entered Into A License Agreement For Two Bispecific Antibodies In The Field Of Autoimmune And Inflammatory Bowel Diseases, HXN-1002 and HXN-1003, For An Upfront Payment Of $125M And $1.72B In Milestone Payments

Hooker Furnishings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFT#NASDAQ">HOFT</a>) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $0.16 by 237.5 percent. This is a 466.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $104.46 million which beat the analyst consensus estimate of $101.16 million by 3.26 percent. This is a 7.94 percent increase over sales of $96.78 million the same period last year.

Hooker Furnishings Q4 EPS $(0.22) Misses $0.16 Estimate, Sales $104.46M Beat $101.16M Estimate

Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) reported quarterly earnings of $0.87 per share which met the analyst consensus estimate. This is a 3.33 percent decrease over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $4.947 billion which beat the analyst consensus estimate of $4.937 billion by 0.20 percent. This is a 1.56 percent increase over sales of $4.871 billion the same period last year.

Truist Finl Q1 2025 Adj. EPS $0.87, Inline, Sales $4.947B Beat $4.937B Estimate

Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.51 by 5.88 percent. This is a 22.73 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $1.81 billion which missed the analyst consensus estimate of $1.83 billion by 1.10 percent. This is a 0.67 percent increase over sales of $1.80 billion the same period last year.

Regions Finl Q1 Adj $0.54 Beats $0.51 Estimate, Adj Sales $1.81B Miss $1.83B Estimate

Offerings

Marex Group Priced The Public Offering Of 10.28M Shares By Certain Selling Shareholders At $35.50 Per Share. The Selling Shareholders Have Granted The Underwriters An Option To Purchase Up To An Additional 1.54M Shares

UnitedHealth Group revised its 2025 performance outlook established in December 2024 to net earnings of $24.65 to $25.15 per share and adjusted earnings of $26 to $26.50 per share. This outlook reflects two factors:
<ul>
<li>Heightened care activity indications within UnitedHealthcare's Medicare Advantage businesses, which became visible as the quarter closed, far above the planned 2025 increase which was consistent with the elevated levels in 2024. This activity was most notable within physician and outpatient services.</li>
<li>Unanticipated changes in the profile of Optum Health members impacting planned 2025 reimbursement due to unexpectedly minimal 2024 beneficiary engagement by plans exiting markets. In addition, a greater-than-expected impact to current and new complex patients from the ongoing Medicare funding reductions enacted by the previous administration.</li>
</ul>

UnitedHealth Expects 2025 Adjusted EPS Of $26-$26.50 Versus Prior Guidance Of $29.50-$30.00 And Consensus Of $29.73

President Donald Trump's auto tariffs are expected to drive up car insurance and repair costs, <a href="https://www.benzinga.com/general/travel/25/04/44785814/car-insurance-premiums-are-set-to-go-through-the-roof-soon-due-to-trumps-auto-tariffs">affecting even drivers who aren't buying new vehicles</a>. What Happened: Trump&#8217;s&nbsp;25% tariffs on imported vehicles&nbsp;are slated to extend to foreign-made auto parts by May 3. Despite hints of potential leniency from Trump, experts predict that the heightened trade barriers will eventually dent consumers&#8217; pockets, NBC News <a href="https://www.nbcnews.com/data-graphics/trump-tariffs-car-insurance-bill-price-auto-repair-cost-rcna201392?ref=biztoc.com">reported</a> on Wednesday.
Auto insurance costs have been climbing for several years, and a prolonged trade war could push&nbsp;the average annual cost of&nbsp;car insurance up by over&nbsp;$300 by the end of&nbsp;the year, with New York and Florida&nbsp;predicted to experience the steepest increases, according to <a href="https://insurify.com/car-insurance/report/">estimates</a>&nbsp;from Insurify.
The rationale is straightforward: insurance companies will have to shell out&nbsp;more to replace damaged car&nbsp;parts that are subject to&nbsp;tariffs. &#8220;When&nbsp;you get into an accident,&nbsp;your car insurance company is&nbsp;the one that&#8217;s&nbsp;going to be buying those&nbsp;parts to repair your vehicle,&#8221; said&nbsp;Terence Lau, dean of Syracuse&nbsp;University's College of Law.
See Also:&nbsp;<a href="https://www.benzinga.com/25/04/44857599/ford-could-hike-prices-of-its-vehicles-in-the-us-amid-auto-tariff-uncertainty-report">Trump Tariffs Could Force Ford To Hike Prices Of Its Vehicles In The US Days After It Extended Employee Pricing To All Customers</a>
Many vehicles are susceptible&nbsp;to multiple Trump administration tariff&nbsp;policies, impacting not only the auto industry but also&nbsp;levies on steel and aluminum,&nbsp;taxes on chips, and duties on global imports.
Why It Matters: Consumers have been scrambling to <a href="https://www.benzinga.com/25/04/44817399/liberation-day-tariffs-why-some-americans-are-rushing-to-buy-a-car-before-trumps-25-auto-duty-hits">purchase cars before the tariffs instigate price increases</a>. Retail sales figures released by the Commerce Department on Wednesday show a 5.3% surge in&nbsp;sales at motor vehicle and&nbsp;parts dealers from February to March. 
Meanwhile, inventories of used vehicles have declined from 43 to 39 days from March to April, according to Cox Automotive.
The tariffs may put companies like Ford Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) at high risk of <a href="https://www.benzinga.com/news/25/04/44806252/trump-tariffs-could-put-ford-gm-at-high-risk-of-negative-ratings-report">receiving negative ratings</a> from ratings agency S&amp;P.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44857599/ford-could-hike-prices-of-its-vehicles-in-the-us-amid-auto-tariff-uncertainty-report">Trump Tariffs Could Force Ford To Hike Prices Of Its Vehicles In The US, Days After It Extended Employee Pricing To All Customers</a></li>
</ul>
Photo courtesy: Brandon Woyshnis / Shutterstock.com

Not Buying A New Car? You May Still Pay An Extra $300 Due To Trump's Auto Tariffs: Here's More

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported quarterly earnings of $7.20 per share which missed the analyst consensus estimate of $7.29 by 1.23 percent. This is a 4.2 percent increase over earnings of $6.91 per share from the same period last year. The company reported quarterly sales of $109.58 billion which missed the analyst consensus estimate of $111.60 billion by 1.82 percent. This is a 9.80 percent increase over sales of $99.80 billion the same period last year.

UnitedHealth Group Q1 2025 Adj EPS $7.20 Misses $7.29 Estimate, Sales $109.58B Miss $111.60B Estimate

Press Releases

Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial

Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial

Opinion

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Repare Therapeutics Announces Leadership Transitions

CRGX

IMRX

ONCY

RNXT

TSX:ONC

Adicet Bio

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Avalo Therapeutics

BeyondSpring

Cabaletta Bio

Cibus

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

CytomX Therapeutics

Citius Oncology

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Forte Biosciences

Gain Therapeutics

ImmuCell

Immix Biopharma

Immuneering Corporation - Class A Common Stock

Immuneering

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

MAIA Biotechnology

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

PMV Pharma

Quince Therapeutics

Serina Therapeutics

Skye Bioscience

Sutro Biopharma

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

HC Wainwright & Co.

Stifel

Piper Sandler

Morgan Stanley

2025년 4월 11일 금요일, 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 유아이패스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), 프라임 메디슨(NGM:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/prme" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for PRME" data-google-interstitial="false">PRME</a>) 및 리페어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>)의 주식을 매도하는 주목할 만한 거래를 실행했다.
PATH 거래
아크 인베스트의 ARK 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)는 유아이패스의 주식 4,256주를 매도했다. 거래 당일 종가인 $10.87를 기준으로, 거래 총액은 약 $46,280.32에 달한다.
유아이패스의 주가는 이날 2.26% 소폭 상승했다.
PRME 거래
프라임 메디슨은 아크 인베스트가 지분을 줄이기로 결정한 또 다른 회사다. ARKK 펀드는 PRME의 주식 83,510주를 매도했다. 거래 당일 주가는 $1.33에 마감했으며, 매도된 주식의 가치는 약 $111,068.30에 이른다.
흥미롭게도, PRME의 주가는 거래 당일 13.68% 급등했다.
참고:<a href="https://www.benzinga.com/news/management/25/04/44774273/jpmorgan-ceo-jamie-dimon-expects-sp-500-growth-forecast-to-be-cut"> JP모건 CEO 제이미 다이먼, S&amp;P 500 성장 전망이 하향 조정될 것으로 예상</a>
RPTX 거래
아크 인베스트의 아크 유전체 혁명 ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) 펀드는 리페 테라퓨틱스의 주식을 매각했다. 이 펀드는 RPTX의 주식 130,611주를 매도했으며, 거래 당일 종가인 $0.9를 기준으로 거래 총액은 약 $117,549.90이다. 주가는 거래 당일 변동이 없었다.
이번 거래는 <a href="https://www.benzinga.com/25/04/44753971/cathie-woods-thursday-plays-healthcare-ai-and-crypto-ark-scoops-up-tempus-ai-and-coinbase-stock-amid-trump-tariff-crash">아크 인베스트가 이전에 수행한 거래</a>에 따른 것으로, 경제적 불확실성과 트럼프 행정부의 중국에 대한 145% 관세 발표로 인한 급격한 시장 매도 속에서 템퍼스 AI와 코인베이스 글로벌 주식을 대량 매수한 것이 특징이다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/04/44774554/analyst-says-recession-chance-higher-than-50-musks-doge-cuts-to-knock-out-gdp-were-getting-closer-to-recession">애널리스트, 경기침체 확률 50% 이상, 머스크의 DOGE가 GDP를 &#8216;타격&#8217;하기 위한 감소 — &#8216;우리는 &#8216;경기침체에 가까워지고 있다&#8217;</a></li>
</ul>
면책 조항: 이 콘텐츠는 AI 도구의 도움을 받아 부분적으로 제작되었으며, 벤징가 편집자에 의해 검토 및 게시되었다.
사진 제공: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

2025년 4월 4일 금요일에 캐시 우드가 이끄는 아크 인베스트는 코인베이스 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), 아마존닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), 크리스퍼 테라퓨틱스 AG(NGM:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/crsp" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for CRSP">CRSP</a>), 빔 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>), 유아이패스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), 로블록스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), 메르카도리브레(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), 그리고 리페어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>)를 포함한 여러 저명한 기업에 대해 상당한 거래를 했다.
COIN 거래
아크 인베스트는 여러 ETF를 통해 코인베이스 글로벌의 주식을 구매했다. 아크 인베스트의 ARK 핀테크 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)는 12,187주를 구매했으며, ARK 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)와 ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 각각 54,988주와 15,982주를 추가했다.
구매된 COIN 주식의 총 가치는 마지막 종가 160.55달러를 기준으로 약 1350만 달러에 해당한다.
AMZN 거래
아마존닷컴도 아크 인베스트로부터 상당한 매수세를 보았다. ARKF, ARKK, 그리고 ARK 자율 기술 및 로보틱스 ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>)는 각각 9,018주, 25,528주 및 8,408주를 구매했다.
아마존의 마지막 종가가 171.0달러인 점을 고려할 때, 구매된 주식의 총 가치는 약 740만 달러이다.
CRSP 및 BEAM 거래
ARKK 기금은 크리스퍼 테라퓨틱스 AG의 69,011주와 빔 테라퓨틱스의 142,713주를 구매했다. 각각의 마지막 종가가 32.65달러와 15.27달러인 점을 바탕으로, 구매된 CRSP 및 BEAM 주식의 총 가치는 약 350만 달러이다.
PATH 거래
아크 인베스트의 ARKK는 유아이패스 주식회사의 448,505주를 매도했으며, ARKQ는 147,575주를 매도했다. ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 323,575주를 매도했으며, ARKF 기금은 434,637주를 매도했다.
RBLX, MELI, 및 RPTX 거래
아크 인베스트는 로블록스와 메르카도리브레의 주식을 여러 ETF를 통해 매도했다. 또한, ARKG 기금은 리페어 테라퓨틱스의 32,613주를 매도했으며, 이는 마지막 종가 1.0달러를 기준으로 약 32,613달러에 해당한다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/25/04/44652222/trumps-tariffs-may-shift-us-spending-from-goods-to-services-creating-uncertainty-for-ecommerce-and-advertising-industries-analyst-warns">관세가 최종 수요에 영향을 미칠 것: 골드만삭스 분석가가 기업 지출 및 고용에 대한 저항을 예상한다</a> </li>
</ul>
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 작성되었으며, Benzinga 편집자에 의해 검토 및 게시되었다.
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

목요일(3일) 캐시 우드가 이끄는 아크 인베스트는 로빈후드 마켓츠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>)의 주식을 매입하며 의미 있는 행보를 보였다. 이번 전략적 투자는 로빈후드가 플랫폼을 지속적으로 확장하고 금융 서비스 제공을 강화하면서 이루어졌다.
<h3>로빈후드 거래</h3>
아크 인베스트는 목요일에 로빈후드 주식 36,250주를 매입했다. 이번 거래는 ARK 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)를 통해 실행되었고 종가 38.26달러를 기준으로 약 139만 달러 규모였다. 로빈후드 주식은 도널드 트럼프 대통령의 무역 관세 부과로 촉발된 광범위한 <a href="https://in.benzinga.com/government/regulations/25/04/44631916/wall-street-wipes-out-2-trillion-apple-eyes-worst-day-since-covid-19-pandemic-oil-plummets-whats-driving-markets-thursday" target="_blank" rel="noopener">시장 침체</a> 속에서 10% 이상 조정되었다. 이러한 움직임은 로빈후드에 대한 아크 인베스트의 투자 이후 나타났다.
수요일(2일) 아크 인베스트는 ARKK를 통해 로빈후드 주식 6,875주를 매입했고 거래의 가치는 약 293,425달러였다. 아크 인베스트는 이번 주에도 로빈후드 주식을 꾸준히 매입하고 있다. 월요일에는 132만 달러 상당의 <a href="https://www.benzinga.com/25/03/44576678/cathie-wood-defies-coreweave-ipo-slump-ark-snaps-up-3-6-million-worth-of-stock-in-nvidia-backed-company" target="_blank" rel="noopener">로빈후드 주식</a>을 매입했고, 화요일에는 328,764달러 상당의 <a href="https://in.benzinga.com/25/04/44599184/cathie-woods-tuesday-bet-ark-loads-up-on-more-robinhood-stock-amid-platform-expansion" target="_blank" rel="noopener">7,798주를 추가 매입했다.</a>
로빈후드는 최근 <a href="https://www.benzinga.com/news/25/03/44528951/robinhood-expands-into-banking-will-offer-customers-4-savings-apy-and-cash-home-delivery" target="_blank" rel="noopener">통합 금융 서비스 제품군</a>을 출시하면서 큰 변화를 겪고 있다. 여기에는 연 4%의 경쟁력 있는 수익률을 제공하는 당좌 예금 및 저축 예금 계좌를 제공하는 로빈후드 뱅킹(Robinhood Banking) 도입이 포함된다. 또한 코스탈 파이낸셜의 자회사인 코스탈 커뮤니티 은행(Coastal Community Bank)을 통해 최대 250만 달러까지 연방예금보험공사의 보험 혜택을 제공한다. 이번 서비스 확장은 보다 정교한 프라이빗 뱅킹 및 투자 솔루션을 찾는 개인 투자자를 유치하는 것을 목표로 한다.
<h3>기타 주요 거래</h3>
<ul>
<li>유아이패스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>): ARKF에서 41,130주, ARKW에서 302,251주 매도</li>
<li>리페어 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>): ARKG에서 119,913주 매도</li>
<li>깃랩 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>): ARKK에서 21,209주, ARKW에서 6,222주 매입</li>
</ul>
이미지 출처: Shutterstock
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 사용하여 생성되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal">Shivdeep Dhaliwal</a>이 편집했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

3월 28일 금요일, 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 로빈후드 마켓(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), 로블록스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) 및 코어위브(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) 등 여러 저명한 기업에 대한 대규모 거래를 진행했다.
로빈후드 거래: 아크 인베스트의 아크 이노베이션 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)는 로빈후드 주식 249,423주를 대량으로 구매했다.
거래 당일 종가인 41.92달러를 기준으로 이 구매의 가치는 약 1,045만 달러로 추정된다.
로블록스 거래: 같은 날 아크 인베스트의 ARKK와 ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 로블록스(Roblox Corp) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>)의 주식 350,177주를 총 매도했다.
종가인 59.07달러를 감안할 때, 매도된 주식의 가치는 약 2,070만 달러이다.
코어위브 거래: 아크 인베스트의 ARKW ETF는 엔비디아의 지원을 받는 코어위브 주식 411,875주를 구매했다.
종가인 59.07달러를 기준으로 매도된 주식의 가치는 약 1,647만 달러이다.
기타 주요 거래:
<ul>
<li>아크 인베스트의 ARKW ETF는 지니어스 스포츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>)의 주식 224,052주를 매도했다.</li>
<li>ARKW는 로쿠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>)의 주식 50,666주를 매도했다.</li>
<li>ARKW는 스포티파이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>)의 주식 6,625주를 매도했다.</li>
<li>아크 인베스트의 ARK 유전체 혁신 ET(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)는 리페어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>)의 주식 46,940주를 매도했다.</li>
</ul>
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/25/03/44549941/elon-musk-to-visit-cia-for-government-efficiency-talks-after-department-of-defense">일론 머스크, 국방부 회의 후 CIA 방문 예정</a></li>
</ul>
면책 조항: 이 콘텐츠는 AI 도구의 도움을 받아 부분적으로 생성되었으며, 벤징가 편집자에 의해 검토 및 게시되었다.
사진 출처: 아크 인베스트
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

CRWV

GENI

ROKU

SPOT

아크 인베스트, 엔비디아 후원의 코어위브 및 로빈후드 주식 매수: 스포티파이·로쿠 매각

2025년 3월 21일 금요일, 캐시 우드가 이끄는 아크 인베스트는 몇 가지 주목할 만한 거래를 진행했으며, 여기에는 상당한 매수와 매도가 포함되었다.
아크 인베스트의 펀드는 이리듐 커뮤니케이션스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>), 빔 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>), 퍼시픽 바이오사이언스 오브 캘리포니아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>), 및 앱시 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>)를 매수한 반면, 일루미나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), 리페어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>), 암젠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), 및 비바 시스템즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>)의 주식을 매도했다.
IRDM 거래: 아크 인베스트의 ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>), ARK Autonomous Technology &amp; Robotics ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>), 및 ARK Space Exploration &amp; Innovation ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) 펀드가 이리듐 커뮤니케이션스의 주식 68,355주를 총 매수했다.
마지막 종가 27.65달러를 기준으로 매수한 주식들의 총 가치는 약 189만 달러이다.
BEAM 거래: 아크 인베스트의 ARKK 및 Ark Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) 펀드가 총 28,717주의 빔 테라퓨틱스주식을 매수했다.
마지막 종가 23.3달러을 기준으로 매수한 주식들의 총 가치는 약 669,106달러이다.
PACB 거래: 아크 인베스트의 ARKK 펀드가 퍼시픽 바이오사이언스 오브 캘리포니아의 주식 243,300주를 매수했다.
마지막 종가 1.3달러를 기준으로 매수한 주식들의 총 가치는 약 316,290달러이다.
기타 주요 거래:
<ul>
<li>일루미나: 아크 인베스트는 ARKK와 ARKG를 통해 총 42,616주의 주식을 매도했다.</li>
<li>앱시 코퍼레이션: 아크 인베스트는 ARKG를 통해 71,392주의 주식을 매수했습니다.</li>
<li>리페어 테라퓨틱스: 아크 인베스트는 ARKG를 통해 54,786주의 주식을 매도했다.</li>
<li>암젠: 아크 인베스트는 ARKG를 통해 990주의 주식을 매도했다.</li>
<li>비바 시스템즈: 아크 인베스트는 ARKG를 통해 1,322주의 주식을 매도했다.</li>
</ul>
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44434973/tesla-record-highest-trade-ins-amid-backlash-against-ceo-elon-musk-surge-in-vandalism">테슬라, CEO 일론 머스크에 대한 반발과 기물 파손 급증 속 역대 최고 거래량 기록</a></li>
</ul>
면책 조항: 이 내용은 AI 도구의 도움을 받아 부분적으로 작성되었으며, Benzinga 편집자에 의해 검토되고 게시되었습니다.
사진 제공: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

ABSI

AMGN

ARKX

ILMN

IRDM

PACB

VEEV

아크 인베스트가 이리듐·빔·퍼시픽 바이오사이언스를 매수, 일루미나와 암젠을 매각

2025년 3월 14일 금요일, 캐시 우드가 이끄는 아크 인베스트가 깃랩(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>), 인텔리아 테라퓨틱스(NGM:<a href="https://www.benzinga.com/quote/ntla" target="_blank" rel="noopener">NTLA</a>), 프라임 메디슨(NGM:<a href="https://www.benzinga.com/report/PRME" target="_blank" rel="noopener">PRME</a>), 유아이패스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), 아이보타(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>), 로블록스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), 리페어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) 및 케어DX(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>)에 대해 큰 매매를 했다.
PATH 거래:
아크 인베스트의 ARK 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)와 ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)가 유아이패스의 주식을 매도했다. ARKK 펀드는 1,092,269주를 매도했고, ARKW 펀드는 158,650주를 매도했다.
주가가 10.88달러로 마감됨에 따라, 매도된 주식의 총 가치는 약 1,361만 달러였다.
RBLX 거래:
아크 인베스트의 ARK 핀테크 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)와 ARKW 펀드가 로블록스의 주식을 매도했습니다. ARKF 펀드는 10,057주를 매도했고, ARKW 펀드는 28,700주를 매도했다.
주가가 56.51달러로 마감됨에 따라, 매도된 주식의 총 가치는 약 219만 달러였다.
GTLB 거래:
아크 인베스트의 ARKK 펀드가 깃랩의 주식 81,543주를 매수했다. 주가가 52.08달러로 마감됨에 따라, 약 424만 달러의 투자로 환산되었다.
또한 ARKW 펀드도 깃랩의 주식 22,610주를 매수하여 약 118만 달러를 투자했다.
NTLA 거래:
아크 인베스트의 ARK 유전자 혁명 ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)와 ARKK 펀드가 인텔리아 테라퓨틱스의 주식을 매수했다. ARKG 펀드는 11,276주를 매수했고, ARKK 펀드는 56,244주를 매수했다.
주가가 9.14달러로 마감됨에 따라, 총 투자액은 약 62만 달러였다.
PRME 거래:
아크 인베스트의 ARKK 펀드가 프라임 메디슨의 주식 46,026주를 매도했다. 주가가 1.79달러로 마감됨에 따라, 매도된 주식의 총 가치는 약 82,386달러였다.
IBTA 거래:
아크 인베스트의 ARKF와 ARKW 펀이 아이보타의 주식을 매수했다. ARKF 펀드는 10,967주를 매수했고, ARKW 펀드는 68,234주를 매수했다.
주가가 37.87달러로 마감됨에 따라, 총 투자액은 약 299만 달러였다.
RPTX 거래:
아크 인베스트의 ARKG 펀드가 리페어 테라퓨틱스의 주식 53,449주를 매도했다.
주가가 1.1달러로 마감됨에 따라, 매도된 주식의 총 가치는 약 58,794달러였다.
CDNA 거래:
아크 인베스트의 ARKG 펀드가 케어DX의 주식 47,153주를 매도했다. 주가가 18.9달러로 마감됨에 따라, 매도된 주식의 총 가치는 약 891,191달러였다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/25/03/44345022/ray-dalio-has-a-chilling-warning-for-president-trump-debt-crisis-is-imminent-and-an-issue-of-paramount-importance">레이 달리오가 트럼프 대통령에게 내린 소름끼치는 경고: 부채 위기는 임박했으며 &#8216;가장 중요한 문제&#8217;입니다.</a></li>
</ul>
면책 조항: 이 콘텐츠는 AI 도구의 도움을 받아 부분적으로 생성되었으며 Benzinga 편집자에 의해 검토되고 게시되었습니다.
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

CDNA

IBTA

NTLA

아크 인베스트: 유아이패스와 로블록스 주식을 계속 처분, 깃랩과 아이보타를 매수

Comments

Repare Therapeutics

뉴스

에 대한 최신 뉴스 Repare Therapeutics (NASDAQ:RPTX) 주식

토요일, 4월 12, 2025

토요일, 4월 05, 2025

금요일, 4월 04, 2025

토요일, 3월 29, 2025

토요일, 3월 22, 2025

토요일, 3월 15, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌